Economic and health consequence frames affect COVID-19 vaccine incentive attitudes in Germany- a survey based framing experiment

经济和健康后果框架影响德国民众对新冠疫苗的激励态度——一项基于调查的框架实验

阅读:1

Abstract

BACKGROUND: SARS-CoV-2 vaccines have significantly reduced human and economic losses. Nevertheless, vaccine hesitancy remains a major issue in many countries, including Germany. Recent studies have shown that public health framing and incentives can boost immunization rates. However, available evidence is fragmented and inconclusive regarding the effectiveness of different framing messages, types of incentives, and the size of financial incentives across different populations. METHODS: This randomized, controlled survey experiment elicited the attitudes of 6,685 Germans towards 4 financial/non-financial SARS-CoV-2 immunization incentives (food voucher, football tickets, participation in lottery, immediate monetary compensation), and tested whether framing (individual/collective, health/economic consequences) affected said attitudes. We assigned participants to five study arms (control: no frame; experiment: 1 of 4 frames) and measured attitudes towards immunization incentives, and the amount of monetary compensation deemed appropriate, should such an incentive be considered. RESULTS: While > 75% of our sample considered all 4 incentives to be not meaningful, all frames increased favorable views towards the financial incentives lottery/money and the average amount deemed acceptable for immediate monetary compensation. Interaction models showed that all frames have similar effects across core subgroups, e.g. age-cohorts, gender, vaccine doses. CONCLUSIONS: Across a sample of 6,685 Germans, we show that 4 different frames detailing the potential individual/collective consequences of COVID-19 have very similar effects on attitudes towards monetary incentives for SARS-CoV-2 immunization. Our results suggest that the existence of frames rather than specific narratives is key to increasing favorable views towards immunization incentives. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。